Breath Therapeutics raised €44M in a Series A round in Mar 2017. The company is based in Munich, Germany. Investors in the round: Gilde Healthcare, GIMV, Sofinnova Partners. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €44M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
